Upexi (UPXI) Competitors

Upexi (NASDAQ:UPXI) and FibroBiologics (NASDAQ:FBLG) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk.

Do institutionals and insiders hold more shares of UPXI or FBLG?

5.7% of Upexi shares are owned by institutional investors. 34.7% of Upexi shares are owned by company insiders. Comparatively, 20.8% of FibroBiologics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the media prefer UPXI or FBLG?

In the previous week, Upexi had 7 more articles in the media than FibroBiologics. MarketBeat recorded 10 mentions for Upexi and 3 mentions for FibroBiologics. Upexi's average media sentiment score of 0.87 beat FibroBiologics' score of 0.72 indicating that Upexi is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Upexi	1 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
FibroBiologics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is UPXI or FBLG more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Upexi	N/A	N/A	N/A
FibroBiologics	N/A	N/A	-225.34%

Which has preferable earnings and valuation, UPXI or FBLG?

FibroBiologics has lower revenue, but higher earnings than Upexi.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upexi	$18.63M	0.85	-$23.66M	N/A	N/A
FibroBiologics	N/A	N/A	-$16.49M	-$0.34	-3.00

Does the MarketBeat Community favor UPXI or FBLG?

FibroBiologics received 10 more outperform votes than Upexi when rated by MarketBeat users. Likewise, 100.00% of users gave FibroBiologics an outperform vote while only 42.86% of users gave Upexi an outperform vote.

Company	Underperform	Outperform
Upexi	Outperform Votes 3 42.86%	Underperform Votes 4 57.14%
FibroBiologics	Outperform Votes 13 100.00%	Underperform Votes No Votes

Which has more risk & volatility, UPXI or FBLG?

Upexi has a beta of 0.35, meaning that its share price is 65% less volatile than the S&P 500. Comparatively, FibroBiologics has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500.

Do analysts prefer UPXI or FBLG?

FibroBiologics has a consensus price target of $13.00, suggesting a potential upside of 1,174.51%. Given FibroBiologics' stronger consensus rating and higher possible upside, analysts clearly believe FibroBiologics is more favorable than Upexi.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upexi	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
FibroBiologics	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.20

Summary

Upexi and FibroBiologics tied by winning 7 of the 14 factors compared between the two stocks.